A retrospective evaluation of therapeutic efficacy and safety of chemoradiotherapy in older patients (aged ≥ 75 years) with limited-disease small cell lung cancer: Insights from two institutions: Chemoradiotherapy in older patients with limited-disease small cell lung cancer. (2024). Radiology and Oncology, 58(3), 432-443. https://www.radioloncol.com/index.php/ro/article/view/4269